Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study.
Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study. J Clin Oncol. 2010 Jun 01; 28(16):2727-31.
View in:
PubMed
subject areas
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Biopsy, Needle
Biopsy, Needle
Carboplatin
Carboplatin
Carcinosarcoma
Carcinosarcoma
Confidence Intervals
Confidence Intervals
Disease-Free Survival
Disease-Free Survival
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Administration Schedule
Female
Female
Humans
Humans
Immunohistochemistry
Immunohistochemistry
Infusions, Intravenous
Infusions, Intravenous
Kaplan-Meier Estimate
Kaplan-Meier Estimate
Maximum Tolerated Dose
Maximum Tolerated Dose
Middle Aged
Middle Aged
Neoplasm Invasiveness
Neoplasm Invasiveness
Neoplasm Staging
Neoplasm Staging
Paclitaxel
Paclitaxel
Probability
Probability
Prognosis
Prognosis
Program Evaluation
Program Evaluation
Risk Assessment
Risk Assessment
Survival Analysis
Survival Analysis
Treatment Outcome
Treatment Outcome
Uterine Neoplasms
Uterine Neoplasms
authors with profiles
Robert S Mannel